US2010003192A1PendingUtilityA1

Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents

62
Assignee: BIPAR SCIENCES INCPriority: Nov 12, 2007Filed: Jul 1, 2009Published: Jan 7, 2010
Est. expiryNov 12, 2027(~1.3 yrs left)· nominal 20-yr term from priority
Inventors:Barry M. ShermanCharles BradleyValeria Ossovskaya
A61P 35/00A61P 43/00A61P 35/04A61K 31/282A61K 41/00A61K 45/06A61K 31/555A61K 31/337A61K 2300/00A61P 15/00A61K 31/166A61K 31/7068A61K 31/00A61P 15/14
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

In one aspect, the present invention provides a method of treating breast cancer that is negative for at least one of ER, PR, or HER2, comprising administering to a subject at least one PARP inhibitor. In another aspect, the present invention provides a method of treating breast cancer comprising administering to a subject at least one PARP inhibitor in combination with at least one anti-tumor agent.

Claims

exact text as granted — not AI-modified
1 . A method of treating breast cancer that is negative for at least one of ER, PR, or HER2 in a patient, comprising administering to the patient at least one PARP inhibitor. 
   
   
       2 - 131 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.